Annual report pursuant to Section 13 and 15(d)

STOCKHOLDERS' EQUITY

v3.19.3.a.u2
STOCKHOLDERS' EQUITY
12 Months Ended
Dec. 31, 2019
STOCKHOLDERS' EQUITY  
STOCKHOLDERS' EQUITY

NOTE 7. STOCKHOLDERS’ EQUITY

Preferred Stock  — The Company  filed an Amended and Restated Certificate of Incorporation in February 2019 such that the Company is authorized to issue up to 5,000,000 shares of preferred stock with a par value of $0.0001 per share with such designations,  voting and other rights and preferences as may be determined  from time to time by the Company’s board of directors. At December 31, 2019 and 2018, there were no shares of preferred stock issued or outstanding.

Common Stock — The Company filed an Amended and Restated Certificate of Incorporation in February 2019 such that the Company is authorized to issue up to 200,000,000 shares of common stock with a par value of $0.0001 per share. Holders of common stock are entitled to one vote for each share. At December 31, 2019 and 2018, there were 5,285,054 and 4,312,500 shares of common stock issued and outstanding, excluding 16,994,946 and -0- shares of common stock subject to possible redemption, respectively.

Warrants — The Public Warrants will become exercisable 30 days after the completion of a Business Combination provided that the Company has an effective registration statement under the Securities Act covering the shares of common stock issuable upon exercise of the Public Warrants and a current prospectus relating to them is available. Notwithstanding the foregoing, if a registration statement  covering the issuance of the shares issuable upon exercise of the Public Warrants is not effective within 90 days from the closing of a Business Combination, warrant holders may, until such time as there is an effective registration statement  and during any period when the Company  shall have failed to maintain  an effective registration statement  or a current prospectus,  exercise warrants  on a cashless basis pursuant to an available exemption from registration under the Securities Act. If an exemption from registration is not available, holders will not be able to exercise their warrants  on a cashless basis. In no event will the Company  be required to net cash settle any warrant, or issue securities or other compensation in exchange for the warrants in the event that the Company  is unable to register or qualify the shares underlying the warrants under the Securities Act or applicable state securities laws. In addition, any Private Warrants held by Cowen will not be exercisable more than five years from the effective date of the registration statement. The Public Warrants will expire five years after the completion  of a Business Combination or earlier upon redemption or liquidation.

Once the warrants  become exercisable, the Company  may redeem the Public Warrants:

·

in whole and not in part;

·

at a price of  $0.01 per warrant;

·

upon a minimum of 30 days’ prior written notice of redemption; and

·

if, and only if, the reported  last sale price of the Company’s common stock equals or exceeds $18.00 per share for any 20 trading days within a 30‑trading day period ending on the third trading day prior to the date on which the Company  sends the notice of redemption to the warrant holders.

The Private Warrants are identical to the Public Warrants underlying the Units sold in the Initial Public Offering, except that the Private Warrants and the common stock issuable upon the exercise of the Private Warrants will not be transferable, assignable or salable until after the completion  of a Business Combination, subject to certain limited exceptions. Additionally, the Private Warrants will be exercisable on a cashless basis and be non-redeemable so long as they are held by the initial purchasers  or their permitted  transferees. If the Private Warrants are held by someone other than the initial purchasers  or their permitted  transferees, the Private Warrants will be redeemable by the Company  and exercisable by such holders on the same basis as the Public Warrants.

If the Company  calls the Public Warrants for redemption, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. The exercise price and number of shares of common stock issuable upon exercise of the warrants  may be adjusted in certain circumstances including in the event of a stock dividend, or recapitalization, reorganization, merger or consolidation. However, the warrants  will not be adjusted for issuance of common stock at a price below its exercise price. Additionally, in no event will the Company  be required to net cash settle the warrants. If the Company  is unable to complete a Business Combination within the Combination Period and the Company  liquidates the funds held in the Trust Account,  holders of warrants  will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants  may expire worthless.